欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Erlotinib Hydrochloride_183319-69-9_产品详情
183319-69-9
  • Erlotinib Hydrochloride

  • names:

    Erlotinib Hydrochloride

  • CAS号:

    183319-69-9

    MDL Number:
  • MF(分子式): C22H24ClN3O4 MW(分子量): 429.9
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Erlotinib Hydrochloride
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001855-500mg 500mg 99.99% ¥ 1620.00 ¥ 1620.00 2-3天
- +
¥ 0.00
YZM001855-100mg 100mg 99.99% ¥ 650.00 ¥ 650.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 183319-69-9
Inchi
InchiKey
分子式 Formula C22H24ClN3O4
分子量 Molecular Weight 429.9
溶解度Solubility 生物体外In Vitro:DMSO溶解度6.2 mg/mL(14.42 mM;Need ultrasonic and warming)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
Erlotinib Hydrochloride(CAS:183319-69-9)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 Erlotinib Hydrochloride (CP-358774 Hydrochloride) 抑制EGFR激酶的IC50为 2 nM
IntroductionErlotinib Hydrochloride (CP58774 Hydrochloride) inhibits purifiedEGFRkinase with anIC50of 2 nM.
Application1
Application2
Application3
Erlotinib Hydrochloride (CP-358774 Hydrochloride) 抑制EGFR激酶的IC50为 2 nM。Erlotinib Hydrochloride (CP-358774 Hydrochloride) inhibits purifiedEGFRkinase with anIC50of 2 nM.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Moyer JD, et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res. 1997 Nov 1;57(21):4838-48.
【2】.Ali S, et al. Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer. Mol Cancer Ther, 2008, 7(6), 1708-1719.
【3】.Marchetti S, et al. Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-typ
【4】.Adachi K, et al. Effects of erlotinib on lung injury induced by intratracheal administration of bleomycin (BLM) in rats. J Toxicol Sci. 2010 Aug;35(4):503-14.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents